Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    "Epidermolysis bullosa"
Show Display Options
RSS Create an RSS feed from your search for:
"Epidermolysis bullosa"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Study of Alwextin® Cream in Treating Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Alwextin cream
2 Terminated
Has Results
Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: fludarabine phosphate;   Procedure: hematopoietic bone marrow transplantation
3 Terminated A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing
Condition: Epidermolysis Bullosa
Interventions: Biological: ABH001;   Other: Control wound treatment
4 Active, not recruiting Open Label Extension Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: SD-101 dermal cream (6%)
5 Completed Study of Effectiveness and Safety of SD-101 in Subjects With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: 3% SD-101 dermal cream;   Drug: 6% SD-101 dermal cream;   Drug: Vehicle (0% SD-101)
6 Completed The Efficacy of Trimethoprim in Wound Healing of Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Trimethoprim
7 Recruiting ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: SD-101-6.0 cream;   Drug: SD-101-0.0 cream
8 Active, not recruiting Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: Zorblisa (SD-101-6.0) cream
9 Recruiting Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention: Other: Allogeneic mesenchymal stem cells
10 Withdrawn A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Interventions: Biological: HP802-247;   Other: Placebo
11 Completed Case Series Documentation of Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa Hereditaria
Intervention: Drug: Sericare®
12 Terminated
Has Results
A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Thymosin Beta 4;   Drug: Placebo
13 Unknown  Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Condition: Epidermolysis Bullosa
Intervention: Drug: Reduced Intensity Transplant conditioning
14 Recruiting Stem Cell Transplant for Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Anti-thymocyte globulin;   Drug: Cyclosporine A;   Drug: Mycophenolate mofetil;   Procedure: Mesenchymal stem cell transplantation;   Radiation: Total body irradiation;   Procedure: Bone marrow or umbilical cord blood (UCG) stem cell transplantation
15 Withdrawn Grafting of Epidermolysis Bullosa Wounds Using Cultured Revertant Autologous Keratinocytes
Condition: Epidermolysis Bullosa
Intervention: Procedure: Grafting of Autologous Cultured Revertant Keratinocytes
16 Withdrawn Prospective, Longitudinal Natural History Study in Dystrophic Epidermolysis Bullosa
Condition: Dystrophic Epidermolysis Bullosa
Intervention:
17 Recruiting Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: topical BPM31510 3.0% Cream
18 Completed Study of Inflammatory Mechanisms in Epidermolysis Bullosa Simplex- Dowling Meara
Condition: Epidermolysis Bullosa Simplex Dowling Meara
Intervention: Procedure: Taking of liquid and top of blisters
19 Unknown  Randomised Double Blind Crossover Placebo Controlled Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa
Condition: Epidermolysis Bullosa
Intervention: Drug: tetracyclin
20 Unknown  Treatment of Dowling Maera Type of Epidermolysis Bullosa Simplex by Oral Erythromycin
Condition: Epidermolysis Bullosa
Intervention: Drug: Oral erythromycin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.